BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16236857)

  • 1. Alpha1-antitrypsin deficiency in 26-year-old subjects: lung, liver, and protease/protease inhibitor studies.
    Piitulainen E; Carlson J; Ohlsson K; Sveger T
    Chest; 2005 Oct; 128(4):2076-81. PubMed ID: 16236857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adolescents with alpha1-antitrypsin deficiency have high alpha2-macroglobulin and low neutrophil lipocalin and elastase levels in plasma.
    Sveger T; Ohlsson K; Piitulainen E
    Pediatr Res; 1998 Dec; 44(6):939-41. PubMed ID: 9853931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Swedish α1-Antitrypsin Screening Study: Health Status and Lung and Liver Function at Age 34.
    Tanash HA; Nystedt-Düzakin M; Montero LC; Sveger T; Piitulainen E
    Ann Am Thorac Soc; 2015 Jun; 12(6):807-12. PubMed ID: 25803183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory symptoms and lung function in 30-year-old individuals with alpha-1-antitrypsin deficiency.
    Bernspång E; Sveger T; Piitulainen E
    Respir Med; 2007 Sep; 101(9):1971-6. PubMed ID: 17532199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years.
    Piitulainen E; Mostafavi B; Tanash HA
    Int J Chron Obstruct Pulmon Dis; 2017; 12():495-500. PubMed ID: 28203073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver function in alpha-1-antitrypsin deficient individuals at 37 to 40 years of age.
    Mostafavi B; Diaz S; Tanash HA; Piitulainen E
    Medicine (Baltimore); 2017 Mar; 96(12):e6180. PubMed ID: 28328804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung function and CT lung densitometry in 37- to 39-year-old individuals with alpha-1-antitrypsin deficiency.
    Mostafavi B; Diaz S; Piitulainen E; Stoel BC; Wollmer P; Tanash HA
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3689-3698. PubMed ID: 30510411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The liver in adolescents with alpha 1-antitrypsin deficiency.
    Sveger T; Eriksson S
    Hepatology; 1995 Aug; 22(2):514-7. PubMed ID: 7635419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endotoxin receptor CD14 in PiZ alpha-1-antitrypsin deficiency individuals.
    Sandström CS; Novoradovskaya N; Cilio CM; Piitulainen E; Sveger T; Janciauskiene S
    Respir Res; 2008 Apr; 9(1):34. PubMed ID: 18426570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency.
    Hollander C; Westin U; Wallmark A; Piitulainen E; Sveger T; Janciauskiene SM
    BMC Pulm Med; 2007 Jan; 7():1. PubMed ID: 17261175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung Function and CT Densitometry in Subjects with alpha-1-Antitrypsin Deficiency and Healthy Controls at 35 Years of Age.
    Piitulainen E; Montero LC; Nystedt-Düzakin M; Stoel BC; Sveger T; Wollmer P; Tanash HA; Diaz S
    COPD; 2015 Apr; 12(2):162-7. PubMed ID: 25280185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory symptoms and lung function in young adults with severe alpha(1)-antitrypsin deficiency (PiZZ).
    Piitulainen E; Sveger T
    Thorax; 2002 Aug; 57(8):705-8. PubMed ID: 12149531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clarifying the Risk of Lung Disease in SZ Alpha-1 Antitrypsin Deficiency.
    Franciosi AN; Hobbs BD; McElvaney OJ; Molloy K; Hersh C; Clarke L; Gunaratnam C; Silverman EK; Carroll TP; McElvaney NG
    Am J Respir Crit Care Med; 2020 Jul; 202(1):73-82. PubMed ID: 32197047
    [No Abstract]   [Full Text] [Related]  

  • 14. Lung function in adolescents with alpha 1-antitrypsin deficiency.
    Sveger T; Piitulainen E; Arborelius M
    Acta Paediatr; 1994 Nov; 83(11):1170-3. PubMed ID: 7841733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ).
    Hill AT; Campbell EJ; Bayley DL; Hill SL; Stockley RA
    Am J Respir Crit Care Med; 1999 Dec; 160(6):1968-75. PubMed ID: 10588615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung function in 30-year-old alpha-1-antitrypsin-deficient individuals.
    Bernspång E; Wollmer P; Sveger T; Piitulainen E
    Respir Med; 2009 Jun; 103(6):861-5. PubMed ID: 19181511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT lung densitometry in young adults with alpha-1-antitrypsin deficiency.
    Bernspång E; Diaz S; Stoel B; Wollmer P; Sveger T; Piitulainen E
    Respir Med; 2011 Jan; 105(1):74-9. PubMed ID: 20674322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive smoking diminishes the differences in quality of life and exacerbation frequency between the alpha-1-antitrypsin deficiency genotypes PiZZ and PiSZ.
    Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R; Fähndrich S
    Respir Med; 2017 Sep; 130():1-8. PubMed ID: 29206626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of environmental and clinical factors on lung function and respiratory symptoms in adolescents with alpha1-antitrypsin deficiency.
    Piitulainen E; Sveger T
    Acta Paediatr; 1998 Nov; 87(11):1120-4. PubMed ID: 9846912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma protease inhibitors in alpha 1-antitrypsin-deficient children.
    Sveger T
    Pediatr Res; 1985 Aug; 19(8):834-5. PubMed ID: 3875830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.